Tamim  Niazi

Assistant Professor

Oncology

Address:
Department of Oncology, Division of Radiation Oncology
Jewish General Hospital
Room G-002
3755 Côte Ste. Catherine Road
Montréal, Québec, H3T 1E2

Telephone: (514) 340-8288

Education: MD, McGill University

Clinical Focus: Radiation Oncology; GU Malignancies (Prostate, Bladder, Testicle); GI Malignancies (Stomach, Pancreas, Rectum, Anal Canal); Gynecological Malignancies (Cervix and Uterus)

Research Focus: Intensity Modulated Radiotherapy (IMRT); High Dose Rate (HDR) Brachytherapy; Stereotactic Radiosurgery; Image Guided Radiotherapy (IGRT); Prostate Cancer


Recent Presentations:

Cardiovascular effect of androgen deprivation therapy in Prostate cancer patients treated LHRH agonist, March 2017, Montreal, Canada.

LHRH agonist vs. antagonist and the risk of CVD. April, 2017, Ottawa.

Cardiovascular effect of androgen deprivation therapy in Prostate cancer patients treated LHRH agonist, April 2017, Toronto, Canada.

Prostate Coveted program, testosterone breakthrough and cardiovascular impact of ADT in prostate cancer patients. May 2017, Vanouver. Canada

Stereotactic bordy radiotherapy (SBRT) in prostate oligometastatic patients. departmental grand round, May 2017, London. Ontario. Canada

Moderately Hypofractionated radiation therapy in localized prostate cancer, attelier cancer de prostate, May 2017, Montreal. Canada

Stereotactic bordy radiotherapy (SBRT) in prostate oligometastatic patients. departmental grand round, May 2017, Charle le Moyen Hospital. South Shore, Quebec. Canada.

Xtandi and radiation therapy for prostate cancer patients with oligometastases. Jewish General Hospital , May 2017. Montreal Canada.

Testosterone Nadir and biochemical failure. Post ASCO GU. April, 2017 Montreal, Canada


Recent Publications:

Please click here for Dr. Tamim Niazi’s complete publication list.